서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 18 of 18

Issue DateTitle / Author(s) / CitationFileAltmetrics
2002
Preventive and therapeutic effects of oral tolerance in a murine model of asthma
link
2014-06
Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation
DOI
2014-11
Tumor-derived osteopontin suppresses antitumor immunity by promoting extramedullary myelopoiesis
DOI
2017-06
IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
DOI
2018-06
IL21 therapy combined with PD-1 and Tim-3 blockade provides enhanced NK cell antitumor activity against MHC class I-deficient tumors
DOI
2018-09
Activation of NKT cells in an anti-PD-1-resistant tumor model enhances antitumor immunity by reinvigorating exhausted CD8 T cells
DOI
2019-03
GM-CSF promotes antitumor immunity by inducing Th9 cell responses
DOI
2019-07
Roles of NKT cells in cancer immunotherapy

Bae, Eun-Ah; Seo, Hyungseok; Kim, Il-Kyu; Jeon, Insu; Kang, Chang-Yuil

Archives of Pharmacal Research, Vol.42 No.7, pp.543-548

DOI
2019-08
Monocyte-derived dendritic cells dictate the memory differentiation of CD8+ T cells during acute infection
DOI
2020-01
Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16-or 18-Positive Recurrent Cervical Cancer
DOI
2020-03
Differentiation of c-Kit(+)CD24(+) natural killer cells into myeloid cells in a GATA-2-dependent manner
DOI
2020-05
GITR Agonism Triggers Antitumor Immune Responses through IL21-Expressing Follicular Helper T Cells
DOI
2020-09
Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses
DOI
2021-06
Type 17 immunity promotes the exhaustion of CD8 + T cells in cancer
DOI
2021-08
Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia
DOI
2022-05
The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates
DOI
2024-02
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials
DOI
2024-03
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform
DOI
1